Showing results 7620 to 7639 of 19105
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 2009 | G protein-coupled receptor kinase 6 controls post-inflammatory visceral hyperalgesia | Eijkelkamp, N.; Heijnen, C.; Elsenbruch, S.; Holtmann, G.; Schedlowski, M.; Kavelaars, A. |
| 2017 | G-CSF receptor blockade ameliorates arthritic pain and disease | Lee, M.; McCubbin, J.; Christensen, A.; Poole, D.; Rajasekhar, P.; Lieu, T.; Bunnett, N.; Garcia Caraballo, S.; Erickson, A.; Brierley, S.; Saleh, R.; Achuthan, A.; Fleetwood, A.; Anderson, R.; Hamilton, J.; Cook, A. |
| 2004 | G-protein β3 subunit 825CC genotype is associated with unexplained (functional) dyspepsia | Holtmann, G.; Siffert, W.; Haag, S.; Mueller, N.; Langkafel, M.; Senf, W.; Zotz, R.; Talley, N. |
| 1998 | GABAB receptor antagonism by 7-MBFG, a benzo[b]furan analogue of baclofen, in central and peripheral tissues | Ong, J.; Kerr, D.; Ansar, M.; Vaccher, C.; Berthelot, P. |
| 1996 | GABAB receptor antagonism by resolved (R)-saclofen in the guinea pig ileum | Kerr, D.; Ong, J.; Vaccher, C.; Berthelot, P.; Floquet, N.; Vaccher, M.P.; Debaert, M. |
| 2000 | GABAB receptor-mediated effects on vagal pathways to the lower oesophageal sphincter and heart | Blackshaw, L.; Smid, S.; Dent, J.; O'Donnell, T. |
| 2000 | GABAB receptors - peripheral and central targets for controlling gastroesophageal reflux | Blackshaw, L.; Page, A.; Smid, S.; Dent, J.; Lehmann, A. |
| 1999 | GABAB Receptors Inhibit Mechanosensitivity of Primary Afferent Endings | Page, A.; Blackshaw, L. |
| 2001 | GABAB receptors on vagal afferent pathways: peripheral and central inhibition | Partosoedarso, E.; Young, R.; Blackshaw, L. |
| 1997 | GABAB receptors: Role and therapeutic implications | Bowery, N.; Kerr, D.; Ong, J. |
| 1996 | GABAB receptors: targets for drug development | Kerr, D.; Ong, J. |
| 2001 | GABABR expressed on vagal afferent neurones inhibit gastric mechanosensitivity in ferret proximal stomach | Smid, S.; Young, R.; Isaacs, N.; Blackshaw, L. |
| 2013 | GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutations | Perugini, M.; Iarossi, D.; Kok, C.; Cummings, N.; Diakiw, S.; Brown, A.; Danner, S.; Bardy, P.; To, L.; Wei, A.; Lewis, I.; D'Andrea, R. |
| 2008 | Gain and loss of gastrointestinal symptoms in diabetes mellitus: associations with psychiatric disease, glycemic control, and autonomic neuropathy over 2 years of follow-up | Quan, C.; Talley, N.; Jones, M.; Spies, J.; Horowitz, M. |
| 2023 | Gain of chromosome 21 increases the propensity for P2RY8: :CRLF2 acute lymphoblastic leukemia via increased HMGN1 expression | Page, E.C.; Heatley, S.L.; Rehn, J.; Thomas, P.Q.; Yeung, D.T.; White, D.L. |
| 2022 | Gait biomechanics after proximal femoral nailing of intertrochanteric fractures | Sivakumar, A.; Rickman, M.; Thewlis, D. |
| 2001 | Gait disorders accompanying diseases of the frontal lobes | Thompson, P. |
| 2013 | Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial | Morrissey, C.O.; Chen, S.C.A.; Sorrell, T.C.; Milliken, S.; Bardy, P.G.; Bradstock, K.F.; Szer, J.; Halliday, C.L.; Gilroy, N.M.; Moore, J.; Schwarer, A.P.; Guy, S.; Bajel, A.; Tramontana, A.R.; Spelman, T.; Slavin, M.A. |
| 2019 | Galectin-3 is associated with stage B metabolic heart disease and pulmonary hypertension in young obese patients | Gopal, D.M.; Ayalon, N.; Wang, Y.-C.; Siwik, D.; Sverdlov, A.; Donohue, C.; Perez, A.; Downing, J.; Apovian, C.; Silva, V.; Panagia, M.; Kolachalama, V.; Ho, J.E.; Liang, C.-S.; Gokce, N.; Colucci, W.S. |
| 2011 | Gallbladder Surgery: Laparoscopic Cholecystectomy and Management of Bile Duct Stones in the Rural Setting | Harsh, K.; Strickland, A.; Wichmann, M.; Borgstrom, D.; Caron, N.; Maddern, G. |
